International Reviews of Immunology最新文献_第3页

RNA methylation: A potential therapeutic target in autoimmune disease. RNA甲基化:自身免疫性疾病的潜在治疗靶点

IF 4.3 4区医学

International Reviews of Immunology Pub Date : 2024-05-01 Epub Date: 2023-11-17 DOI: 10.1080/08830185.2023.2280544

Lele Li, Xiaoping Xia, Tian Yang, Yuchao Sun, Xueke Liu, Wei Xu, Mei Lu, Dawei Cui, Yingping Wu

{"title":"RNA methylation: A potential therapeutic target in autoimmune disease.","authors":"Lele Li, Xiaoping Xia, Tian Yang, Yuchao Sun, Xueke Liu, Wei Xu, Mei Lu, Dawei Cui, Yingping Wu","doi":"10.1080/08830185.2023.2280544","DOIUrl":"10.1080/08830185.2023.2280544","url":null,"abstract":"Autoimmune diseases such as rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), and inflammatory bowel disease (IBD) are caused by the body's immune response to autoantigens. The pathogenesis of autoimmune diseases is unclear. Numerous studies have demonstrated that RNA methylation plays a key role in disease progression, which is essential for post-transcriptional regulation and has gradually become a broad regulatory mechanism that controls gene expression in various physiological processes, including RNA nuclear output, translation, splicing, and noncoding RNA processing. Here, we outline the writers, erasers, and readers of RNA methylation, including N6-methyladenosine (m6A), 2'-O-methylation (Nm), 2'-O-dimethyladenosine (m6Am), N1-methyladenosine (m1A), 5-methylcytidine (m5C) and N7-methylguanosine (m7G). As the role of RNA methylation modifications in the immune system and diseases is explained, the potential treatment value of these modifications has also been demonstrated. This review reports the relationship between RNA methylation and autoimmune diseases, highlighting the need for future research into the therapeutic potential of RNA modifications.","PeriodicalId":14333,"journal":{"name":"International Reviews of Immunology","volume":" ","pages":"160-177"},"PeriodicalIF":4.3,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136397400","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Cerebral malaria pathogenesis: Dissecting the role of CD4+ and CD8+ T-cells as major effectors in disease pathology 脑疟疾发病机制：剖析 CD4+ 和 CD8+ T 细胞作为主要效应因子在疾病病理学中的作用

IF 5 4区医学

International Reviews of Immunology Pub Date : 2024-04-15 DOI: 10.1080/08830185.2024.2336539

Indu Sharma, Poonam Kataria, Jyoti Das

引用次数: 0

The emerging role of T helper 9 (Th9) cells in immunopathophysiology: A comprehensive review of their effects and responsiveness in various disease states. T 辅助细胞 9 (Th9) 在免疫病理生理学中的新作用：全面回顾它们在各种疾病状态中的作用和反应。

IF 4.3 4区医学

International Reviews of Immunology Pub Date : 2024-01-01 Epub Date: 2024-06-12 DOI: 10.1080/08830185.2024.2364586

Manoj Khokhar, Purvi Purohit

{"title":"The emerging role of T helper 9 (Th9) cells in immunopathophysiology: A comprehensive review of their effects and responsiveness in various disease states.","authors":"Manoj Khokhar, Purvi Purohit","doi":"10.1080/08830185.2024.2364586","DOIUrl":"10.1080/08830185.2024.2364586","url":null,"abstract":"Th9 cells, a subset of T-helper cells producing interleukin-9 (IL-9), play a vital role in the adaptive immune response and have diverse effects in different diseases. Regulated by transcription factors like PU.1 and IRF4, and cytokines such as IL-4 and TGF-β, Th9 cells drive tissue inflammation. This review focuses on their emerging role in immunopathophysiology. Th9 cells exhibit immune-mediated cancer cell destruction, showing promise in glioma and cervical cancer treatment. However, their role in breast and lung cancer is intricate, requiring a deeper understanding of pro- and anti-tumor aspects. Th9 cells, along with IL-9, foster T cell and immune cell proliferation, contributing to autoimmune disorders. They are implicated in psoriasis, atopic dermatitis, and infections. In allergic reactions and asthma, Th9 cells fuel pro-inflammatory responses. Targeting Foxo1 may regulate innate and adaptive immune responses, alleviating disease symptoms. This comprehensive review outlines Th9 cells' evolving immunopathophysiological role, emphasizing the necessity for further research to grasp their effects and potential therapeutic applications across diseases.","PeriodicalId":14333,"journal":{"name":"International Reviews of Immunology","volume":" ","pages":"341-360"},"PeriodicalIF":4.3,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141305930","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

STAT4 and STAT6, their role in cellular and humoral immunity and in diverse human diseases. STAT4 和 STAT6，它们在细胞和体液免疫以及各种人类疾病中的作用。

IF 4.3 4区医学

International Reviews of Immunology Pub Date : 2024-01-01 Epub Date: 2024-08-26 DOI: 10.1080/08830185.2024.2395274

Manlio Tolomeo, Antonio Cascio

{"title":"STAT4 and STAT6, their role in cellular and humoral immunity and in diverse human diseases.","authors":"Manlio Tolomeo, Antonio Cascio","doi":"10.1080/08830185.2024.2395274","DOIUrl":"10.1080/08830185.2024.2395274","url":null,"abstract":"Signal transducer and activator of transcription (STAT) 4 and STAT6 play a crucial role in immune cells by transducing signals from specific cytokine receptors, and inducing transcription of genes involved in cell-mediated and humoral immunity. These two different defense mechanisms against pathogens are regulated by two specific CD4+ T helper (Th) cells known as Th1 and Th2 cells. Many studies have shown that several diseases including cancer, inflammatory, autoimmune and allergic diseases are associated with a Th1/Th2 imbalance caused by increased or decreased expression/activity of STAT4 or STAT6 often due to genetic and epigenetic aberrances. An altered expression of STAT4 has been observed in different tumors and autoimmune diseases, while a dysregulation of STAT6 signaling pathway is frequently observed in allergic conditions, such as atopic dermatitis, allergic asthma, food allergy, and tumors such as Hodgkin and non-Hodgkin lymphomas. Recently, dysregulations of STAT4 and STAT6 expression have been observed in SARS-CoV2 and monkeypox infections, which are still public health emergencies in many countries. SARS-CoV-2 can induce an imbalance in Th1 and Th2 responses with a predominant activation of STAT6 in the cytosol and nuclei of pneumocytes that drives Th2 polarization and cytokine storm. In monkeypox infection the virus can promote an immune evasion by inducing a Th2 response that in turn inhibits the Th1 response essential for virus elimination. Furthermore, genetic variations of STAT4 that are associated with an increased risk of developing systemic lupus erythematosus seem to play a role in defense against SARS-CoV-2 infection.","PeriodicalId":14333,"journal":{"name":"International Reviews of Immunology","volume":" ","pages":"394-418"},"PeriodicalIF":4.3,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142072800","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Orchestration of immune response by innate lymphoid cell subtype 2 at various tumor microenvironment, a suitable target for cancer immunotherapy. 先天性淋巴细胞亚型 2 在各种肿瘤微环境中协调免疫反应，是癌症免疫疗法的合适靶点。

IF 5 4区医学

International Reviews of Immunology Pub Date : 2024-01-01 Epub Date: 2023-08-21 DOI: 10.1080/08830185.2023.2247021

Rajdeep Roy, Tanmoy Das, Nabendu Biswas

{"title":"Orchestration of immune response by innate lymphoid cell subtype 2 at various tumor microenvironment, a suitable target for cancer immunotherapy.","authors":"Rajdeep Roy, Tanmoy Das, Nabendu Biswas","doi":"10.1080/08830185.2023.2247021","DOIUrl":"10.1080/08830185.2023.2247021","url":null,"abstract":"Innate lymphoid cells are a mixed population of cells and critical regulators of our innate immune system. According to recent scientific literature, tissue resident innate lymphoid cell subtype 2 has been recognized as an important player of type 2 inflammatory responses, involved in different human malignancies like pancreatic, lung, acute myeloid leukemia, gastrointestinal tract cancer, etc. The current reports have revealed that, among the three main ILC sub types, subtype 2 (ILC 2), as the key regulator of initiating the type 2 inflammatory responses at the tumor microenvironment (TME). This activation of ILC-2 is a very important step for the specific downstream functioning of ILC-2. Priming of ILC-2 with different chemokines involves different cytokine secretion from the activated ILC-2 like IL-4, IL-5, IL-13, IL-9 which induce type 2 inflammatory responses involved in the complex interaction with other immune cells like NK cell, Cytotoxic T cell, MDSC and Treg cell. At the initial stage, ILC-2 activation through IL-33 may induce the anti-tumorigenic effect mediated by ILC-2/eosinophil axis. However, it is also evident that PDG2 (Prostaglandin D2)-mediated activation of ILC-2 induces the ILC-2/MDSC immune suppressive pro-tumorigenic niche at the TME. Here, in this review, we have summarized the function of ILC-2 on cancer immunity based on recent scientific work which indicates ILC-2 plays a dual role and orchestrates the immune responses toward type 2 immunity in different cancer settings.","PeriodicalId":14333,"journal":{"name":"International Reviews of Immunology","volume":" ","pages":"74-82"},"PeriodicalIF":5.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10031627","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Cholesterol: A friend to viruses. 胆固醇病毒的朋友

IF 5 4区医学

International Reviews of Immunology Pub Date : 2024-01-01 Epub Date: 2024-02-19 DOI: 10.1080/08830185.2024.2314577

Yingchun Wang, Lifen Gao

引用次数: 0

Circulating and intestinal regulatory T cells in inflammatory bowel disease: A systemic review and meta-analysis. 炎症性肠病中的循环和肠道调节性 T 细胞：系统回顾与荟萃分析

IF 4.3 4区医学

International Reviews of Immunology Pub Date : 2024-01-01 Epub Date: 2023-08-24 DOI: 10.1080/08830185.2023.2249525

Shihao Duan, Yubin Cao, Pingrun Chen, Yi Yang, Yan Zhang

{"title":"Circulating and intestinal regulatory T cells in inflammatory bowel disease: A systemic review and meta-analysis.","authors":"Shihao Duan, Yubin Cao, Pingrun Chen, Yi Yang, Yan Zhang","doi":"10.1080/08830185.2023.2249525","DOIUrl":"10.1080/08830185.2023.2249525","url":null,"abstract":"Regulatory T cells (Tregs) play an important immunosuppressive role in inflammatory bowel disease (IBD). However, findings on the quantitative and functional changes of intestinal and circulating Tregs in patients with IBD are rather contradictory. We therefore conducted a meta-analysis on this issue. The pooled effect was assessed using the standardized mean difference (SMD) with a 95% confidence interval (CI), and subgroup analyses were performed to investigate heterogeneity. This analysis included 764 IBD (402 UC and 362 CD) patients and 341 healthy controls (HCs) pooled from 17 eligible studies. The percentage of circulating Tregs was significantly decreased in active IBD patients compared to HCs (SMD = -0.95, p < 0.001) and inactive IBD patients (SMD = -0.80, p < 0.001). There was no difference in the percentage of circulating Tregs between inactive IBD patients and HCs. The suppressive function of circulating Tregs was impaired in active IBD patients according to limited data (SMD = -0.75, p = 0.02). Besides, the percentage of intestinal Tregs was significantly higher in inflamed regions than in non-inflamed regions (SMD = 0.85, p < 0.001). Our study quantitatively summarized the quantitative and functional changes of Tregs and supported the therapeutic potential of Tregs in IBD. Moreover, additional research into the functions and characteristics of intestinal Tregs in IBD is needed.","PeriodicalId":14333,"journal":{"name":"International Reviews of Immunology","volume":" ","pages":"83-94"},"PeriodicalIF":4.3,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10435129","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Gut microbiome as a treatment in colorectal cancer. 将肠道微生物组作为结直肠癌的治疗手段。

IF 5 4区医学

International Reviews of Immunology Pub Date : 2024-01-01 Epub Date: 2024-02-12 DOI: 10.1080/08830185.2024.2312294

Murad Khan, Suleman Shah, Wahid Shah, Ikram Khan, Hamid Ali, Ijaz Ali, Riaz Ullah, Xiufang Wang, Arshad Mehmood, Yanli Wang

{"title":"Gut microbiome as a treatment in colorectal cancer.","authors":"Murad Khan, Suleman Shah, Wahid Shah, Ikram Khan, Hamid Ali, Ijaz Ali, Riaz Ullah, Xiufang Wang, Arshad Mehmood, Yanli Wang","doi":"10.1080/08830185.2024.2312294","DOIUrl":"10.1080/08830185.2024.2312294","url":null,"abstract":"Background: The gut microbiome plays a role in the development and progression of colorectal cancer (CRC).Aim and objective: This review focuses on whether the gut microbiome is involved in the development and regulation of the host immune system.Methods: The gut microbiome can influence the production and activity of immune cells and molecules that help to maintain the integrity of the intestinal barrier and prevent inflammation. Gut microbiota modulates the anti-cancer immune response. The gut microbiota can influence the function of immune cells, like T cells, that recognize and eliminate cancer cells. Gut microbiota can affect various aspects of cancer progression and the efficacy of various anti-cancer treatments.Results: Gut microbiota provide promise as a potential biomarker to identify the effect of immunotherapy and as a target for modulation to improve the efficacy of immunotherapy in CRC treatment.Conclusion: The potential synergistic effect between the gut microbiome and anti-cancer treatment modalities provides an interest in developing strategies to modulate the gut microbiome to improve the efficacy of anti-cancer treatment.","PeriodicalId":14333,"journal":{"name":"International Reviews of Immunology","volume":" ","pages":"229-247"},"PeriodicalIF":5.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139722498","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Chemokines: A key driver for inflammation in protozoan infection. 趋化因子:原生动物感染炎症的关键驱动因素。

IF 5 4区医学

International Reviews of Immunology Pub Date : 2024-01-01 Epub Date: 2023-11-19 DOI: 10.1080/08830185.2023.2281566

Rubika Chauhan, Mrinalini Tiwari, Amrendra Chaudhary, Reva Sharan Thakur, Veena Pande, Jyoti Das

{"title":"Chemokines: A key driver for inflammation in protozoan infection.","authors":"Rubika Chauhan, Mrinalini Tiwari, Amrendra Chaudhary, Reva Sharan Thakur, Veena Pande, Jyoti Das","doi":"10.1080/08830185.2023.2281566","DOIUrl":"10.1080/08830185.2023.2281566","url":null,"abstract":"Chemokines belong to the group of small proteins within the cytokine family having strong chemo-attractant properties. In most cases, the strong immuno-modulatory role of chemokines is crucial for generating the immune response against pathogens in various protozoan diseases. In this review, we have given a brief update on the classification, characterization, homeostasis, transcellular migration, and immuno-modulatory role of chemokines. Here we will evaluate the potential role of chemokines and their regulation in various protozoan diseases. There is a significant direct relationship between parasitic infection and the recruitment of effector cells of the immune response. Chemokines play an indispensable role in mediating several defense mechanisms against infection, such as leukocyte recruitment and the generation of innate and cell-mediated immunity that aids in controlling/eliminating the pathogen. This process is controlled by the chemotactic movement of chemokines induced as a primary host immune response. We have also addressed that chemokine expressions during infection are time-dependent and orchestrated in a systematic pattern that ultimately assists in generating a protective immune response. Taken together, this review provides a systematic understanding of the complexity of chemokines profiles during protozoan disease conditions and the rationale of targeting chemokines for the development of therapeutic strategies.","PeriodicalId":14333,"journal":{"name":"International Reviews of Immunology","volume":" ","pages":"211-228"},"PeriodicalIF":5.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138046886","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Platelet extracellular vesicles: Darkness and light of autoimmune diseases. 血小板细胞外囊泡：自身免疫性疾病的黑暗与光明

IF 5 4区医学

International Reviews of Immunology Pub Date : 2024-01-01 Epub Date: 2023-06-23 DOI: 10.1080/08830185.2023.2225551

Jingru Chen, Miao Wang, Ying Zhang, Fenglin Zhu, Yanqiu Xu, Guoxiang Yi, Runxiu Zheng, Bin Wu

{"title":"Platelet extracellular vesicles: Darkness and light of autoimmune diseases.","authors":"Jingru Chen, Miao Wang, Ying Zhang, Fenglin Zhu, Yanqiu Xu, Guoxiang Yi, Runxiu Zheng, Bin Wu","doi":"10.1080/08830185.2023.2225551","DOIUrl":"10.1080/08830185.2023.2225551","url":null,"abstract":"Autoimmune diseases are characterized by a breakdown of immune tolerance, leading to inflammation and irreversible end-organ tissue damage. Platelet extracellular vesicles are cellular elements that are important in blood circulation and actively participate in inflammatory and immune responses through intercellular communication and interactions between inflammatory cells, immune cells, and their secreted factors. Therefore, platelet extracellular vesicles are the \"accelerator\" in the pathological process of autoimmune diseases; however, this robust set of functions of platelet extracellular vesicles has also prompted new advances in therapeutic strategies for autoimmune diseases. In this review, we update fundamental mechanisms based on platelet extracellular vesicles communication function in autoimmune diseases. We also focus on the potential role of platelet extracellular vesicles for the treatment of autoimmune diseases. Some recent studies have found that antiplatelet aggregation drugs, specific biological agents can reduce the release of platelet extracellular vesicles. Platelet extracellular vesicles can also serve as vehicles to deliver drugs to targeted cells. It seems that we can try to silence or inhibit microRNA carried by platelet extracellular vesicles transcription and regulate the target cells to treat autoimmune diseases as platelet extracellular vesicles can transfer microRNA to other cells to regulate immune-inflammatory responses. Hopefully, the information presented here will provide hope for patients with autoimmune diseases.","PeriodicalId":14333,"journal":{"name":"International Reviews of Immunology","volume":" ","pages":"63-73"},"PeriodicalIF":5.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10051307","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0